Enablex Related Clinical Trials
Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers. [Not yet recruiting]
Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers. [Not yet recruiting]
2 Week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Yrs) With Neurogenic Detrusor Overactivity [Suspended]
Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain [Recruiting]
Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women [Recruiting]
Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects [Completed]
Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder [Completed]
Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects [Completed]
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over [Completed]
Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder [Completed]
Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder [Completed]
A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder. [Completed]
A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder [Completed]
FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period [Completed]
Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness [Withdrawn]
Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects [Completed]
Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity [Terminated]
Post Marketing Surveillance Study on Emselex After Launch in Germany [Completed]
Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity [Completed]
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease [Completed]
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) [Recruiting]
InSite for Over Active Bladder [Active, not recruiting]
|